This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heistad, D. D. Search for Related Content PubMed Articles by Heistad, D. D.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1.)
© 2007 American Heart Association, Inc.

Editorials

Arteriosclerosis, Thrombosis, and Vascular Biology, 1999–2007

Donald D. Heistad for the Editors

Correspondence to Donald D. Heistad, MD, ATVB Editorial Office, 609 MRC, Cardiovascular Unit, The University of Iowa, Iowa City, IA 52242. E-mail atvb@uiowa.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
This year marks the end of the Iowa City/Fukuoka/Stockholm editorship for Arteriosclerosis, Thrombosis, and Vascular Biology. As we look forward to the transition to new editors in a few months, we will look back on the growth of the journal. Since the first issue in 1981, Arteriosclerosis, Thrombosis, and Vascular Biology has grown in length of title (from Arteriosclerosis), frequency (from bi-monthly), number of manuscripts received (now third among the five AHA journals), and impact factor (also third among AHA journals).

The major goal of our editorship has been to publish high-quality papers that scientists are eager to read. We built on the foundation laid by previous editors, Edwin Bierman (1981–1991) and Alan Fogelman (1991–1999). The journal arguably was and is the premier journal in studies of lipoproteins and mechanisms of atherosclerosis. We perceived that there was an opportunity to become the premier journal in vascular biology. In relation to thrombosis, we focused on developing ATVB as a leading journal for studies of the interaction of blood components with the blood vessel wall.

We will summarize some ways that we sought to achieve our goals, and objective parameters which suggest progress toward the goals. There is a great opportunity for Mark Taubman, the new editor, (and the scientific community that benefits from a strong journal) to facilitate the continued growth of the journal.

	Goals of ATVB

 
Our intangible goals were to publish a journal that scientists look forward to reading and to which they are eager to submit their manuscripts. Intangible . . . [Full Text of this Article]

This article has been cited by other articles:

				R. S. Deeb, R. K. Upmacis, B. D. Lamon, S. S. Gross, and D. P. Hajjar Maintaining Equilibrium by Selective Targeting of Cyclooxygenase Pathways: Promising Offensives Against Vascular Injury Hypertension, January 1, 2008; 51(1): 1 - 7. [Full Text] [PDF]